Torrent Gujarat Biotech Limited
Torrent House, Off. Ashram Road, Ahmedabad- 380 009
Un-audited Financial Results for the Quarter ended September 30, 2005

Notes :
 
1.
Above results were reviewed by the Audit Committee and approved by the Board of Directors in meetings held on October 28, 2005.
2.
The prices of Penicillin-G & Amoxicillin in both, the domestic & the international markets have been falling since July, 2003. Due to the adverse market conditions the production of Penicillin-G has been suspended w.e.f . March 31, 2005 and Derivatives from June14, 2005.
3.
The Company was declared a Sick Industrial Company by Board for Industrial and Financial Reconstruction (BIFR) under the provisions of Section 3(1)(o) of the Sick Industrial Companies (Special Provisions) Act, 1985. A scheme of Rehabilitation has been sanctioned by BIFR vide its Order dated March 10, 2003 and an amount of Rs.6,665 lacs representing the waiver/reduction in liabilities, has been kept in Reconstruction Reserve pending compliance of certain conditions.
4.
The company has entered in to Memorandum of Understanding (MOU) on October 12, 2005 with M/S Sterling Biotech Ltd for sale of its manufacturing facilities at Masar, Tal: Padra, Dist: Vadodara for Rs.55 crores in all cash deal, subject to approval from BIFR, Debenture Trustees, GIIC and Shareholders. Such approvals are yet to be received. The company would enter in to Definitive Assets Transfer Agreement only after receipt of such approvals. Necessary adjustment in the value of fixed assets will be made in the books of accounts, only on completion of the deal.
5.
In absence of taxable income, no provision for Income-tax is considered necessary. The Company has unabsorbed depreciation and carried forward losses under tax laws. In absence of virtual   certainty of sufficient future taxable income, net deferred tax asset has not been recognized in the accounts under review.
6.
The company operates only in one segment i.e. Bulk Drugs.
7.
Accounts of the Company have been prepared on going concern basis. Effect of sale of manufacturing facility as envisaged in the MOU shall be made in the books of accounts on completion of the deal.
8.
The equity shares of the company have been delisted from The Stock Exchange, Ahmedabad w.e.f. October 10, 2005
9.
During the quarter ended September 30,2005, the company has received and disposed off 26 Investors’ complaints. There was no investors’ complaint pending at the beginning and at the end of the quarter.
10.
The figures for the corresponding period have been regrouped wherever necessary to make them comparable.
11.
The results for the quarter ended September 30, 2005 are subject to “Limited Review” by the Statutory Auditors of the Company.